.GAMMA.-GLUTAMYL-S-(2-(2-(3-(((4-CHLORO-3-METHYL-5-ISOXAZOLYL)AMINO)SULFONYL)-2-THIENYL)-2-OXOETHYL)-5,6-DIHYDROXY-3-METHYLPHENYL)-L-CYSTEINYL-GLYCINE, L-
UNII 9Y2LY1JIQK
Substance Identification & Data
This profile provides standardized clinical and technical data for .gamma.-glutamyl-s-(2-(2-(3-(((4-chloro-3-methyl-5-isoxazolyl)amino)sulfonyl)-2-thienyl)-2-oxoethyl)-5,6-dihydroxy-3-methylphenyl)-l-cysteinyl-glycine, L-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9Y2LY1JIQK.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1439124-09-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H30ClN5O12S3 SVBBZUSELHPUJQ-GJZGRUSLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for .gamma.-glutamyl-s-(2-(2-(3-(((4-chloro-3-methyl-5-isoxazolyl)amino)sulfonyl)-2-thienyl)-2-oxoethyl)-5,6-dihydroxy-3-methylphenyl)-l-cysteinyl-glycine, L-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.